Dentsply Sirona (XRAY) $84M Investor Settlement
Dentsply Sirona ($XRAY) has agreed to an $84 million settlement with investors over claims that it misled them about financial reporting and anti-competitive practices.
Between 2014 and 2018, Dentsply Sirona allegedly inflated sales by forcing distributors like Patterson Companies to purchase excess inventory and overstated goodwill tied to those deals. The company was also accused of coordinating with major dental distributors to limit competition and maintain inflated pricing. As these issues came to light, $XRAY dropped over 45%, and Dentsply faced a lawsuit from investors.
September 30, 2017 – Patterson Companies declined to renew its exclusive distribution agreement, exposing Dentsply Sirona’s reliance on inflated sales metrics.
August 7, 2018 – The company disclosed a $1.2 billion goodwill impairment, causing $XRAY to fall 19%.
December 19, 2018 – Investors filed a lawsuit, alleging fraudulent financial reporting and anti-competitive conduct.
December 16, 2020 – The SEC issued a cease-and-desist order, confirming Dentsply Sirona failed to disclose inventory risks and violated financial reporting rules.
March 14, 2025 – Dentsply Sirona agreed to pay a $84 million settlement.
Dentsply Sirona positioned itself as the world’s largest manufacturer of professional dental products, reporting strong sales growth based on exclusive distribution agreements with Patterson Companies.
These agreements required Patterson to purchase large volumes of inventory, even when demand was lower, inflating Dentsply Sirona’s financials.
In 2017, Patterson ended its exclusive agreement, forcing Dentsply Sirona to acknowledge excess inventory and slowing sales. Over the next year, its financial misstatements unraveled, leading to a $1.2 billion goodwill impairment in August 2018, which caused $XRAY to drop 19%.
By December 2018, investors sued, alleging the company misled them about its financial health and engaged in anti-competitive practices to mask declining sales.
In December 2020, the SEC issued a cease-and-desist order, confirming that Dentsply Sirona failed to disclose key financial risks and that its revenue figures were artificially inflated.
Dentsply Sirona ($XRAY) has agreed to an $84 million settlement with investors over claims that it misled them about financial reporting and anti-competitive practices.
If you were affected by this situation, you can file for a payout and receive your share of the settlement. You can check if you are eligible and find more details in the FAQ section below.
Frequently Asked Questions
All persons who purchased or otherwise acquired Dentsply International, or Dentsply Sirona, common stock during the period from December 8, 2015, through August 6, 2018, inclusive, and were damaged thereby
No, if you have purchased securities within the class period, you are eligible to participate.
You can participate in the settlement and retain (or sell) your securities.
The entire process usually takes 4 to 9 months after the claim deadline. But the exact timing depends on the court and settlement administration.
The final payout amount depends on your specific trades and the number of investors participating in the settlement.
If 100% of investors file their claims - the average payout will be $0.4 per share. Although typically only 25% of investors file claims, in this case, the average recovery will be $1.6 per share.
11thestate is an investor recovery company, we help investors to track and collect securities class action settlements. We will:
1. Prepare documents for your payout
2. Audit the claim and make sure you get the maximum possible payout
3. File a claim with the settlement administration
4. Correspond with the settlement administration to resolve emerging issues
5. Deliver payout directly to your brokerage account
There is no upfront cost, but we will deduct 20% of the recovered amount as a commission for our services.